“What do you call a medical student who graduated last in his class? A doctor.”
It’s funny because it’s true. And slightly uncomfortable.
When you’re sitting across from a physician and their diploma is on the wall behind them, you don’t see a class rank or an admissions file. You have no way of knowing the path they took, just that they share the same credentials as everyone else from their graduating class. You want to believe that their path to medical school and through it was as rigorous as possible, because the alternative is terrifying when you or a family member is on the exam table.
That is why what just happened in medical education is more than a bureaucratic tweak — it is a signal that the system is being forced back toward its intended purpose.
Within days of the Justice Department Office for Civil Rights opening a new round of civil rights investigations into medical schools, including a Title VI investigation into Ohio State University College of Medicine, the Liaison Committee on Medical Education quietly stripped its accreditation standards of the diversity, equity, and inclusion language that had, until now, shaped how future doctors are trained. There was no announcement, no attempt to defend the old framework — just a silent revision that removed references to bias, inequities, and diversity from the core requirements every medical school must meet.
The Trump administration has made clear that medical education is not exempt from its broader effort to subject DEI to legal scrutiny, and the accreditor that governs the entire system appears to have responded before it was forced to.
For years, DEI was not an optional add-on to medical training. It was embedded in the accreditation standards themselves. Under the 2026–2027 framework, Standard 7.6 required medical schools to train students to recognize and address bias “in themselves, in others, and in the healthcare delivery process,” alongside instruction on health disparities and culturally competent care. Schools didn’t simply choose to emphasize these ideas — they were required to demonstrate that they had done so.
That framework is now gone. In the 2027-2028 standards, Standard 7.6 has been rewritten to focus on self-directed learning, clinical reasoning, and the ability to identify and address knowledge gaps. The language of bias and inequity has disappeared entirely. What remains is something much closer to the traditional understanding of medical education: Teach students the science, train their judgment, and hold them to a high bar.
That change comes amid a debate that has been building for years about whether the system is selecting and training future doctors in a way that maximizes competence.
Physicians who have been inside that system have been unusually blunt about what is at stake. Houman David Hemmati, a former UCLA medical school admissions committee member, said plainly: “MCAT scores definitely correlate with board exam performance. Linear correlation, in fact. A landmark study in the New England Journal on disciplinary action by medical boards found that later discipline was strongly associated with unprofessional behavior in medical school; those later disciplined had slightly lower MCAT and USMLE Step 1 scores, but the ‘signal’ was much stronger for professionalism than for test scores.”
That is not ideological language — it is data-driven. Preparation shows up in predictable ways, and the traits that matter later — knowledge, discipline, professionalism — tend to appear early. Admissions decisions are filters, and the integrity of those filters matters because they shape everything that follows.
At the same time, the data on how those filters have been applied are not contested or especially controversial. As the American Enterprise Institute has documented, medical school admissions have for years involved substantial racial preferences. One widely cited AEI analysis shows that Black and Hispanic applicants are often admitted with lower MCAT scores and from lower percentile ranges, while Asian and white applicants tend to be admitted with higher scores and from higher percentiles. The chart AEI published illustrates a system that makes different trade-offs for different groups in the name of diversity.
Organizations such as Do No Harm have spent years documenting how these requirements were embedded in the system, turning what might have been a philosophical debate into a concrete one. Then the politics shifted. An executive order on accreditation in 2025 singled out the LCME. And now the DOJ has stepped in with Title VI investigations, treating these issues as potential violations of federal law.
Dr. Kurt Miceli, chief medical officer at Do No Harm, told the Washington Examiner: “Do No Harm commends the LCME for finally removing the remaining DEI language from the latest version of its standards. This reflects a renewed commitment to high-quality clinical care over political ideology.”
Miceli added: “As a powerful institution with significant influence over medical education, the LCME has now made clear that scientific rigor and excellence are the top priorities — a change we have been advocating for years. This marks a major victory and step forward in the ongoing battle over the future of medical education in America. Do No Harm will continue to hold accountable the LCME, accrediting bodies, and medical schools until all traces of biased political ideology are eradicated.”
That is the kind of pressure that produces results. When the question shifts from “is this well-intentioned?” to “is this legally defensible?”, institutions behave differently. They move faster and have less appetite for ideological arguments.
The LCME’s decision to remove DEI language without announcement reflects exactly that dynamic, immediately lowering the institution’s exposure. Importantly, it also signals to medical schools that the ground has shifted.
It is also unmistakably a win for the Trump administration, which has approached DEI not as a cultural norm to be negotiated but as a set of policies to be tested against civil rights law. That approach is now producing tangible changes in one of the most insulated corners of higher education.
What matters more than the politics, though, is what this means for patients.
If admissions standards are softened, if training time is diverted toward material that does not directly improve clinical skill, if the definition of excellence is adjusted to accommodate other priorities, those decisions accumulate.
The rollback of DEI requirements does not guarantee that every doctor will be better trained tomorrow than yesterday, but it removes a set of incentives that were pushing the system away from its central task.
The DOJ investigations ensure that the Trump administration has forced a true recalibration, and that this is not a symbolic shift but a sustained one that will outlast this administration. Medical schools now operate in an environment where their policies are scrutinized not only for their educational value but also for compliance with federal law. That scrutiny has a way of sharpening focus on forcing competence.
For patients, that is not a philosophical win — it is one that will save lives.
The joke about the last-place graduate will never go away. But it hits differently depending on what you believe about the system behind it. If you trust that the system is relentlessly focused on producing the best possible doctors, the joke is harmless. If you suspect that other priorities have crept in, it becomes something else: a reminder of how much is riding on decisions most people will never know or see.
DEMOCRATS OPPOSE ICE ITSELF, NOT ABUSES OR OVERREACH
What the past week suggests is that those decisions are changing, and changing quickly. The accreditor has moved, the regulators are moving, and the system, which for years seemed to be drifting in one direction, is being pulled back in another.
For the people who ultimately depend on that system, that is not just a policy shift. It is a correction with real-world consequences — and, very likely, a safer one.
